Prognostic Significance of TG/HDL-C and Non-HDL-C/HDL-C Ratios in Patients with Non-small Cell Lung Cancer: a Retrospective Study

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2022 Aug 11

PMID 35949158

Authors

Lingxin Kong

Qingtao Zhao

Zhaohui Han

Wenfei Xue

Zhonghui Hu

Zhancong Niu

Guochen Duan

Affiliations

Soon will be listed here.

Abstract

Objective: Lung cancer is a malignancy with high a mortality rate that threatens human health. This study is aimed to explore the correlation among the triglyceride/high-density lipoprotein ratio (TG/HDL-C), non-high-density lipoprotein/high-density lipoprotein ratio (non-HDL-C/HDL-C) and survival of patients with non-small cell lung cancer (NSCLC) undergoing video-associated thoracic surgery (VATS).

Methods: This retrospective study analyzed 284 patients with NSCLC who underwent VATS at Hebei General Hospital, Shijiazhuang, China. The time-dependent receiver operating characteristic curve was used to determine the optimal cutoff value and evaluate the area under the curve. Kaplan-Meier and Cox regression analyses were performed to determine the prognostic effect.

Results: The median overall survival (OS) was 46 months. Patients with low TG/HDL-C and low non-HDL-C/HDL-C had a longer OS. The low non-HDL-C/HDL-C group showed a longer mean survival time (59.00 vs. 52.35 months). Multivariate analysis revealed that TG/HDL-C and non-HDL-C/HDL-C were significantly correlated with OS.

Conclusions: TG/HDL-C and non-HDL-C/HDL-C are associated with the prognosis of patients with NSCLC who received VATS. Preoperative serum TG/HDL-C and non-HDL-C/HDL-C may be effective independent prognostic factors for predicting the outcomes of patients with NSCLC.

Citing Articles

A New Risk Score Based on Lipid Indicators for Patients with Advanced Hepatocellular Carcinoma.

Wei X, Guo Z, Zhang T, Liang J J Hepatocell Carcinoma. 2025; 12:107-121.

PMID: 39867263 PMC: 11762032. DOI: 10.2147/JHC.S505028.

Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patients.

Peng Q, Zhan C, Shen Y, Xu Y, Ren B, Feng Z BMC Cancer. 2024; 24(1):1549.

PMID: 39695484 PMC: 11657272. DOI: 10.1186/s12885-024-13265-8.

Association of non-high-density lipoprotein to high-density lipoprotein ratio (NHHR) with prognosis in cancer survivors: a population-based study in the United States.

Xie W, Liu H, Lin Q, Lian L, Liang B Front Nutr. 2024; 11:1430835.

PMID: 39296499 PMC: 11409846. DOI: 10.3389/fnut.2024.1430835.

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia in individuals with cancer: a cross-sectional study.

He R, Ye Y, Zhu Q, Xie C Lipids Health Dis. 2024; 23(1):217.

PMID: 39014376 PMC: 11251101. DOI: 10.1186/s12944-024-02205-x.

Effects of the subtypes of apolipoprotein E on immune inhibition and prognosis in patients with Hepatocellular Carcinoma.

Gao B, Zhou P, Wang L, Wang Z, Yi Y, Li X J Cancer Res Clin Oncol. 2024; 150(7):341.

PMID: 38976030 PMC: 11230970. DOI: 10.1007/s00432-024-05856-6.

References

Fan Y, Ding X, Wang J, Ma F, Yuan P, Li Q . Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast cancer but not non-TNBCs. Int J Biol Markers. 2015; 30(2):e200-7. DOI: 10.5301/jbm.5000143. View

Xia W, Yao X, Chen Y, Lin J, Vielhauer V, Hu H . Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients. BMC Nephrol. 2020; 21(1):324. PMC: 7398230. DOI: 10.1186/s12882-020-01993-5. View

Peng F, Lei S, Zhang Q, Zhong Y, Wu S . Triglyceride/High-Density Lipoprotein Cholesterol Ratio is Associated with the Mortality of COVID-19: A Retrospective Study in China. Int J Gen Med. 2022; 15:985-996. PMC: 8815778. DOI: 10.2147/IJGM.S346690. View

Li X, Tang H, Wang J, Xie X, Liu P, Kong Y . The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer. Breast. 2016; 32:1-6. DOI: 10.1016/j.breast.2016.11.024. View

Lee Y, Li W, Tsai T, Chiang H, Ting C . Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study. Oncotarget. 2016; 7(16):22948-59. PMC: 5008414. DOI: 10.18632/oncotarget.8312. View

Zhao Q, Yang Y, Xu S, Zhang X, Wang H, Zhang H . Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients. Onco Targets Ther. 2015; 8:2731-8. PMC: 4599071. DOI: 10.2147/OTT.S90875. View

Que Y, Jiang F, Liu L, Li Y, Chen Y, Qiu H . Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma. Medicine (Baltimore). 2015; 94(18):e844. PMC: 4602523. DOI: 10.1097/MD.0000000000000844. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

Li J, Zhang Y, Zheng J . Decreased pretreatment serum cholesterol level is related with poor prognosis in resectable non-small cell lung cancer. Int J Clin Exp Pathol. 2015; 8(9):11877-83. PMC: 4637759. View

10.

Kucharska-Newton A, Rosamond W, Schroeder J, McNeill A, Coresh J, Folsom A . HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study. Lung Cancer. 2008; 61(3):292-300. PMC: 2580072. DOI: 10.1016/j.lungcan.2008.01.015. View

11.

Reuter S, Gupta S, Chaturvedi M, Aggarwal B . Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med. 2010; 49(11):1603-16. PMC: 2990475. DOI: 10.1016/j.freeradbiomed.2010.09.006. View

12.

Ohno Y, Nakashima J, Nakagami Y, Gondo T, Ohori M, Hatano T . Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma. Urology. 2013; 83(1):154-8. DOI: 10.1016/j.urology.2013.08.052. View

13.

Wu J, Chen S, Zhou Y, Wang C, Wang A, Zhang Q . Non-high-density lipoprotein cholesterol on the risks of stroke: a result from the Kailuan study. PLoS One. 2013; 8(9):e74634. PMC: 3769236. DOI: 10.1371/journal.pone.0074634. View

14.

Li J, Li X, Chen X, Ma S . [Research Advances and Obstacles of CT-based Radiomics in Diagnosis and Treatment of Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2020; 23(10):904-908. PMC: 7583873. DOI: 10.3779/j.issn.1009-3419.2020.101.36. View

15.

Zhang Y, Xu J, Lou Y, Hu S, Yu K, Li R . Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non-small-cell lung cancer patients with EGFR mutations. Int J Cancer. 2016; 140(7):1645-1652. DOI: 10.1002/ijc.30581. View

16.

Chi P, Liu W, Chen H, Zhang J, Lin Y, Zheng X . High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma. PLoS One. 2014; 9(3):e91080. PMC: 3953329. DOI: 10.1371/journal.pone.0091080. View

17.

Bays H, Toth P, Kris-Etherton P, Abate N, Aronne L, Brown W . Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013; 7(4):304-83. DOI: 10.1016/j.jacl.2013.04.001. View

18.

Liu B, Tao L, Chen Y, Li X, Dong Y, Ma Y . Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer. PLoS One. 2016; 11(6):e0157401. PMC: 4911005. DOI: 10.1371/journal.pone.0157401. View

19.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

20.

Karayama M, Inui N, Inoue Y, Yoshimura K, Mori K, Hozumi H . Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother. 2021; 71(1):203-217. PMC: 8738455. DOI: 10.1007/s00262-021-02979-4. View